Italy considers easing rules on radiopharmaceuticals
This article was originally published in Clinica
Executive Summary
Italy is considering relaxing some of the regulations governing the handling of radioactive materials for medical use, in a bid to generate "substantial savings" for the nuclear medical sector, says biomedical and diagnostics industries' association, Assobiomedica. The current system penalises the sector with high transport costs, considered to delay access to diagnosis and treatment and to stifle medical research and development.